Liverpool Skylilne

Pharmacy and Biomolecular Sciences

Dr Giles Watts

Dr Giles Watts

Publications

Editorial/letter to the editor

Watts GDJ, Donell S. 2016. Breech presentation is a risk factor for dysplasia of the femoral trochlea Acta Orthopaedica, 87 :207-208 >DOI

Journal article

Mehta SG, Khare M, Ramani R, Watts GDJ, Simon M, Osann KE, Donkervoort S, Dec E, Nalbandian A, Platt J, Pasquali M, Wang A, Mozaffar T, Smith CD, Kimonis VE. 2013. Genotype-phenotype studies of VCP-associated inclusion body myopathy with Paget disease of bone and/or frontotemporal dementia Clinical Genetics, 83 :422-431 >DOI

Nalbandian A, Donkervoort S, Dec E, Badadani M, Katheria V, Rana P, Nguyen C, Mukherjee J, Caiozzo V, Martin B, Watts GD, Vesa J, Smith C, Kimonis VE. 2011. The multiple faces of valosin-containing protein-associated diseases: Inclusion body myopathy with Paget's disease of bone, frontotemporal dementia, and amyotrophic lateral sclerosis Journal of Molecular Neuroscience, 45 :522-531 >DOI

Kimonis VE, Dec E, Badadani M, Nalbandian A, Vesa J, Caiozzo V, Wallace D, Martin B, Smith C, Watts GD. 2011. Clinical Spectrum of VCP Myopathy, Paget Disease, and Frontotemporal Dementia: Experimental Models and Potential Treatments :219-229 >DOI

Badadani M, Nalbandian A, Watts GD, Vesa J, Kitazawa M, Su H, Tanaja J, Dec E, Wallace DC, Mukherjee J, Caiozzo V, Warman M, Kimonis VE. 2010. VCP associated inclusion body myopathy and paget disease of bone knock-in mouse model exhibits tissue pathology typical of human disease PLoS ONE, 5 >DOI

Vesa J, Su H, Watts GD, Krause S, Walter MC, Martin B, Smith C, Wallace DC, Kimonis VE. 2009. Valosin containing protein associated inclusion body myopathy: abnormal vacuolization, autophagy and cell fusion in myoblasts Neuromuscular Disorders, 19 :766-772 >DOI

Barohn RJ, Watts GDJ, Amato AA. 2009. A case of late-onset proximal and distal muscle weakness Neurology, 73 :1592-1597 >DOI

Kimonis VE, Fulchiero E, Vesa J, Watts G. 2008. VCP disease associated with myopathy, Paget disease of bone and frontotemporal dementia: Review of a unique disorder Biochimica et Biophysica Acta - Molecular Basis of Disease, 1782 :744-748 >DOI

Hübbers CU, Clemen CS, Kesper K, Böddrich A, Hofmann A, Kämäräinen O, Tolksdorf K, Stumpf M, Reichelt J, Roth U, Krause S, Watts G, Kimonis V, Wattjes MP, Reimann J, Thal DR, Biermann K, Evert BO, Lochmüller H, Wanker EE, Schoser BGH, Noegel AA, Schröder R. 2007. Pathological consequences of VCP mutations on human striated muscle Brain, 130 :381-393 >DOI

Watts GDG, Thomasova D, Ramdeen SK, Fulchiero EC, Mehta SG, Drachman DA, Weihl CC, Jamrozik Z, Kwiecinski H, Kaminska A, Kimonis VE. 2007. Novel VCP mutations in inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia Clinical Genetics, 72 :420-426 >DOI

Lucas GJA, Mehta SG, Hocking LJ, Stewart TL, Cundy T, Nicholson GC, Walsh JP, Fraser WD, Watts GDJ, Ralston SH, Kimonis VE. 2006. Evaluation of the role of Valosin-containing protein in the pathogenesis of familial and sporadic Paget's disease of bone Bone, 38 :280-285 >DOI

Forman MS, Mackenzie IR, Cairns NJ, Swanson E, Boyer PJ, Drachman DA, Jhaveri BS, Karlawish JH, Pestronk A, Smith TW, Tu PH, Watts GDJ, Markesbery WR, Smith CD, Kimonis VE. 2006. Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations Journal of Neuropathology and Experimental Neurology, 65 :571-581 >DOI

Schröder R, Watts GDJ, Mehta SG, Evert BO, Broich P, Fließbach K, Pauls K, Hans VH, Kimonis V, Thal DR. 2005. Mutant valosin-containing protein causes a novel type of frontotemporal dementia Annals of Neurology, 57 :457-461 >DOI

Kuhlenbäumer G, Hannibal MC, Nelis E, Schirmacher A, Verpoorten N, Meuleman J, Watts GDJ, De Vriendt E, Young P, Stögbauer F, Halfter H, Irobi J, Goossens D, Del-Favero J, Betz BG, Hor H, Kurlemann G, Bird TD, Airaksinen E, Mononen T, Serradell AP, Prats JM, Van Broeckhoven C, De Jonghe P, Timmerman V, Ringelstein EB, Chance PF. 2005. Mutations in SEPT9 cause hereditary neuralgic amyotrophy Nature Genetics, 37 :1044-1046 >DOI

Kimonis VE, Watts GDJ. 2005. Autosomal dominant inclusion body myopathy, Paget disease of bone, and frontotemporal dementia Alzheimer Disease and Associated Disorders, 19 >DOI

Hünermund G, Schirmacher A, Ringelstein B, Young P, Watts GD, Meuleman J, Nelis E, Chance PF, Timmerman V, Stögbauer F, Kuhlenbäumer G. 2004. Genomic organization and mutation analysis of three candidate genes for hereditary neuralgic amyotrophy Muscle and Nerve, 29 :601-604 >DOI

Watts GDJ, Wymer J, Kovach MJ, Mehta SG, Mumm S, Darvish D, Pestronk A, Whyte MP, Kimonis VE. 2004. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein Nature Genetics, 36 :377-381 >DOI

Watts GDJ, Thorne M, Kovach MJ, Pestronk A, Kimonis VE. 2003. Clinical and genetic heterogeneity in chromosome 9p associated hereditary inclusion body myopathy: Exclusion of GNE and three other candidate genes Neuromuscular Disorders, 13 :559-567 >DOI

Watts GDJ, Chance PF. 2002. Molecular basis of hereditary neuropathies. Advances in neurology, 88 :133-146

Watts GDJ, O'Briant KC, Chance PF. 2002. Evidence of a founder effect and refinement of the hereditary neuralgic amyotrophy (HNA) locus on 17q25 in American families Human Genetics, 110 :166-172 >DOI

Jeannet PY, Watts GDJ, Bird TD, Chance PF. 2001. Craniofacial and cutaneous findings expand the phenotype of hereditary neuralgic amyotrophy Neurology, 57 :1963-1968 >DOI

Watts GDJ, O'Briant KC, Borreson TE, Windebank AJ, Chance PF. 2001. Evidence for genetic heterogeneity in hereditary neuralgic amyotrophy Neurology, 56 :675-678 >DOI